v3.26.1
Unaudited Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Sale of product $ 2,671,785 $ 3,655,320 $ 5,050,709 $ 6,894,220
Cost of product 1,312,550 1,513,761 2,540,526 2,720,624
Gross profit 1,359,235 2,141,559 2,510,183 4,173,596
Operating costs and expenses:        
Salaries and contract labor 1,180,904 1,088,832 2,478,521 2,208,158
General, administrative, and consulting 897,806 1,084,907 1,912,041 1,955,931
Research and development 114,774 102,661 263,902 209,364
Total operating expenses 2,193,484 2,276,400 4,654,464 4,373,453
Net operating loss (834,249) (134,841) (2,144,281) (199,857)
Other income (expense):        
Other income 21,821 38,095 54,296 52,444
Interest income 14,441 18,768 28,781 40,592
Interest expense (84,010) (82,807) (168,879) (166,658)
Total other expense (47,748) (25,944) (85,802) (73,622)
Net loss $ (881,997) $ (160,785) $ (2,230,083) $ (273,479)
Net loss per common share - basic: (in dollars per share) $ 0 $ 0 $ 0 $ 0
Net loss per common share - diluted: (in dollars per share) $ 0 $ 0 $ 0 $ 0
Weighted average common shares outstanding - basic (in shares) 529,115,272 527,355,415 528,787,373 525,718,720
Weighted average common shares outstanding - diluted (in shares) 529,115,272 527,355,415 528,787,373 525,718,720